Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Longo

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
Human Heredity|February 24, 2007
Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12pLuca Longo, Emanuele Panza, Francesca Schena, et al.
Oncotarget|August 27, 2015
Identification of GALNT14 as a novel neuroblastoma predisposition geneMarilena De Mariano, Roberta Gallesio, Marco Chierici, et al.
Oncotarget|September 17, 2017
A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastomaMarilena De Mariano, Sara Stigliani, Stefano Moretti, et al.
Plos One|March 4, 2014
NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progressionMassimiliano Monticone, Razieh Taherian, Sara Stigliani, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Linkage analysis in families with recurrent neuroblastomaPatrizia Perri, Luca Longo, Carmel McConville, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Molecules (Basel, Switzerland)|November 13, 2020
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma TreatmentAntonella Brizzolara, Patrizia Garbati, Serena Vella, et al.
International Journal of Cancer|July 12, 2018
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of diseaseMaria Rosaria Esposito, Andrea Binatti, Marcella Pantile, et al.
Oncotarget|September 30, 2016
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cellsAndrea Petretto, Grazia Carbotti, Elvira Inglese, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Immunotherapy|February 25, 2021
Safety and efficacy of immune checkpoint inhibitors in non-small-cell lung cancer: focus on challenging populationsLodovica Zullo, Giovanni Rossi, Chiara Dellepiane, et al.
Human Heredity|February 24, 2007
Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12pLuca Longo, Emanuele Panza, Francesca Schena, et al.
Oncotarget|August 27, 2015
Identification of GALNT14 as a novel neuroblastoma predisposition geneMarilena De Mariano, Roberta Gallesio, Marco Chierici, et al.
Oncotarget|September 17, 2017
A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastomaMarilena De Mariano, Sara Stigliani, Stefano Moretti, et al.
Plos One|March 4, 2014
NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progressionMassimiliano Monticone, Razieh Taherian, Sara Stigliani, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Linkage analysis in families with recurrent neuroblastomaPatrizia Perri, Luca Longo, Carmel McConville, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Molecules (Basel, Switzerland)|November 13, 2020
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma TreatmentAntonella Brizzolara, Patrizia Garbati, Serena Vella, et al.
International Journal of Cancer|July 12, 2018
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of diseaseMaria Rosaria Esposito, Andrea Binatti, Marcella Pantile, et al.
Oncotarget|September 30, 2016
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cellsAndrea Petretto, Grazia Carbotti, Elvira Inglese, et al.
Pageof 6